Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.165 USD | +0.80% | -2.51% | -18.99% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.99% | 1.1B | |
+1.87% | 42.11B | |
+48.83% | 40.08B | |
+8.20% | 40B | |
-10.82% | 26.87B | |
+7.26% | 24.58B | |
-23.49% | 18.44B | |
+1.88% | 11.94B | |
+31.19% | 11.66B | |
+7.57% | 11.01B |
- Stock Market
- Equities
- VIR Stock
- News Vir Biotechnology, Inc.
- Vir Biotechnology : , GSK's Phase 3 Trial of COVID-19 Monoclonal Antibody Meets Primary Endpoint